Max Healthcare continues its impressive growth trajectory under the leadership of CMD Abhai Soi. The company reported robust revenue gains driven by higher OPD visits and a favorable tax impact boosting PAT. EBITDA per bed in existing units rose 7% year-on-year, while Max Lab, the non-captive pathology division, grew 16%. International patient revenue surged 25%, underscoring global trust in Max’s excellence. Operationally, bed capacity expanded to 4,760 from 3,949, with occupancy steady at 77% and average revenue per occupied bed improving by 1%.